Indian Journal of Pharmaceutical Education and Research
Volume 56, Issue 2s (Supplement)
2022 · pp. S121–S373 · 25 articles
- Volume
- 56
- Issue
- 2s
- Published
- 2022
- Pages
- S121–S373
- Articles
- 25
- Sections
- 2
- ISSN
- 0019-5464
- Journal
- IJPER
In this issue
21–25 of 25Original Article(continued)
Anjna Rani, Sunil Kumar, Roop K Khar
pp. S326-S338 · DOI: 10.5530/ijper.56.2s.103 · 2022
Background: Phytosome is a novel technique introduced by Indena that combines standardised herbal extract and phospholipid in preferably equal ratio to provide better absorption enhancing bioavailability. Purpose: The ob…
Prem Prakash Singh, Srividya Gorantla, Ranendra N Saha, Gautam Singhvi
pp. S339-S346 · DOI: 10.5530/ijper.56.2s.104 · 2022
Background: The objective of this work is to develop and validate a reverse-phase HPLC method for determining Loteprednol Etabonate in self micro emulsifying drug delivery systems at nanogram level. Methods: A systematic…
Murthannagari Vivek Reddy, Gonna Nandhi Krishnan Ganesh, Syed Suhaib Ahmed, Praharsh Kumar Mandadhi Rajendra, Eknath Babu
pp. S347-S355 · DOI: 10.5530/ijper.56.2s.105 · 2022
Introduction: Generic drug approval before patent expiration involves patent infringement petitions due to robust Life Cycle Management (LCM) strategies followed by Branded companies. They will extend the patent period o…
Dilip Chandrasekhar, Mohammed Salim Karattuthodi, Linu Mohan Panakkal, Angel Mary William, Anjana A, Annmaria Benny, Aqila Karuppam, Beneta Sarah Sam, Shinu Cholamugath, Jaffer Chalil Parambil, Aneesh Puthiyedath Joy
pp. S356-S364 · DOI: 10.5530/ijper.56.2s.106 · 2022
Introduction: The meteoric spread of COVID-19 had facilitated the researchers to develop vaccines. One among the most recommended, Covishield requires further investigations for lighting up the society towards the immuni…
Nitin Shirsath, Dipak Marathe, Priyanka Jaiswal, Laxmikant Zawar
pp. S365-S373 · DOI: 10.5530/ijper.56.2s.107 · 2022
Background: Azilsartan medoxomil (AZL) is an orally active nonpeptide angiotensin II receptor antagonist with less water solubility and oral bioavailability. Objectives: Increase the solubility and dissolving rate of AZL…

